1. Home
  2. JOF vs SIGA Comparison

JOF vs SIGA Comparison

Compare JOF & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Japan Smaller Capitalization Fund Inc

JOF

Japan Smaller Capitalization Fund Inc

N/A

Current Price

$9.89

Market Cap

273.9M

Sector

Finance

ML Signal

N/A

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

SELL

Current Price

$2.41

Market Cap

223.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JOF
SIGA
Founded
1990
1995
Country
Japan
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.9M
223.8M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
JOF
SIGA
Price
$9.89
$2.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
113.1K
★ 535.8K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
3.33%
★ 22.64%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.09
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$205.62
P/E Ratio
★ N/A
$29.56
Revenue Growth
N/A
N/A
52 Week Low
$10.18
$2.51
52 Week High
$12.85
$7.11

Technical Indicators

Market Signals
Indicator
JOF
SIGA
Relative Strength Index (RSI) 20.86 28.24
Support Level N/A N/A
Resistance Level $11.98 $3.43
Average True Range (ATR) 0.28 0.24
MACD -0.04 -0.06
Stochastic Oscillator 6.60 1.21

Price Performance

Historical Comparison
JOF
SIGA

About JOF Japan Smaller Capitalization Fund Inc

Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: